학술논문

Compliance and Persistence With Ofatumumab Treatment in Patients With Relapsing Multiple Sclerosis in Clinical Trials for Up to 4 Years
Document Type
Journal
Source
NEUROLOGY; APR 25 2023, 100 17, p3169 5p. Supplement: 2
Subject
Language
English
ISSN
1526632X